# CaOx Stone Prevention

> **NCT07225764** · PHASE4 · RECRUITING · sponsor: **Icahn School of Medicine at Mount Sinai** · enrollment: 80 (estimated)

## Conditions studied

- Kidney Stones

## Interventions

- **DRUG:** Chlorthalidone
- **BEHAVIORAL:** Low oxalate diet

## Key facts

- **NCT ID:** NCT07225764
- **Lead sponsor:** Icahn School of Medicine at Mount Sinai
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-23
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-06-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07225764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07225764, "CaOx Stone Prevention". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07225764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*